36 results on '"Delafontaine, Patrice"'
Search Results
2. TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE−/− mice
- Author
-
Sakamuri, Siva Sankara Vara Prasad, Higashi, Yusuke, Sukhanov, Sergiy, Siddesha, Jalahalli M., Delafontaine, Patrice, Siebenlist, Ulrich, and Chandrasekar, Bysani
- Published
- 2016
- Full Text
- View/download PDF
3. An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.
- Author
-
Tadashi Yoshida and Delafontaine, Patrice
- Subjects
- *
CONGESTIVE heart failure , *INTRONS , *ANGIOTENSIN II , *CELL differentiation , *SATELLITE cells , *MUSCLE proteins - Abstract
Patients with advanced congestive heart failure (CHF) or chronic kidney disease often have increased angiotensin II (Ang II) levels and cachexia. We previously demonstrated that Ang II, via its type 1 receptor, causes muscle protein breakdown and apoptosis and inhibits satellite cell (SC) proliferation and muscle regeneration, likely contributing to cachexia in CHF and chronic kidney disease. In contrast, Ang II, via its type 2 receptor (AT2R) expression, is robustly induced during SC differentiation, and it potentiates muscle regeneration. To understand the mechanisms regulating AT2R expression and its potential role in muscle regeneration in chronic diseases, we used a mouse model of CHF and found that muscle regeneration was markedly reduced and that this was accompanied by blunted increase of AT2R expression. We performed AT2R promoter reporter analysis during satellite cell differentiation and found that the 70 bp upstream of the AT2R transcription start site contain a core promoter region, and regions upstream of 70 bp to 3 kbp are dispensable for AT2R induction. Instead, AT2R intron 2 acts as a transcriptional enhancer during SC differentiation. Further deletion/mutation analysis revealed that multiple transcription factor binding sites in the 286/ 690 region within intron 2 coordinately regulate AT2R transcription. Importantly, 286/690 enhancer activity was suppressed in CHF mouse skeletal muscle, suggesting that AT2R expression is suppressed in CHF via inhibition of AT2R intronic enhancer activity, leading to lowered muscle regeneration. Thus targeting intron 2 enhancer element could lead to the development of a novel intervention to increase AT2R expression in SCs and potentiate skeletal muscle regenerative capacity in chronic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Mechanisms of Cachexia in Chronic Disease States.
- Author
-
Tadashi Yoshida and Delafontaine, Patrice
- Published
- 2015
- Full Text
- View/download PDF
5. O211 Urinary Sodium and Potassium Excretion and Cardiovascular Diseases in Patients with Chronic Kidney Disease: the Chronic Renal Insufficiency Cohort study
- Author
-
Mills, Katherine T., Appel, Lawrence J., Chen, Jing, Delafontaine, Patrice, Kusek, John, Ojo, Akinlolu, Rahman, Mahboob, Townsend, Raymond R., Yang, Peter, and He, Jiang
- Published
- 2014
- Full Text
- View/download PDF
6. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.
- Author
-
Kandavar, Ramprasad, Higashi, Yusuke, Chen, Wei, Blackstock, Christopher, Vaughn, Charlotte, Sukhanov, Sergiy, Sander, Gary E., Roffidal, Louise E., Delafontaine, Patrice, and Giles, Thomas D.
- Subjects
HYPERTENSION ,METOPROLOL ,ADRENERGIC beta blockers ,BIOAVAILABILITY ,NITRIC oxide ,ARGININE ,SOMATOMEDIN ,ENZYME-linked immunosorbent assay ,MONOCLONAL antibodies - Abstract
Abstract: This study sought to determine if metoprolol succinate ER (MET), and nebivolol (NEB), a β1-AR with increased bioavailability of nitric oxide (NO), would have differing effects on plasma asymmetric dimethylarginine concentration in hypertensives. It was hypothesized that NEB, a β1-AR antagonist and β3-AR agonist with NO-releasing properties, and MET, only a β1-AR antagonist, would have different effects on plasma asymmetric dimethylarginine (ADMA) concentration. Forty-one hypertensive subjects randomly received either 50 mg of MET (n = 19) or 5 mg of NEB (n = 22) for 4 weeks followed by 100 mg MET and 10 mg NEB for 4 weeks. ADMA and insulin-like growth factor-1 (IGF-1) were measured by enzyme-linked immunosorbent assay kit; endothelial progenitor cells were estimated using fluorescein-labeled monoclonal antibody to KDR and CD133 receptors; arterial augmentation index was measured by radial tonometry. Baseline systolic/diastolic blood pressure was 155.1 ± 18.7/85.3 ± 12.5 mm Hg for MET subjects and 157.6 ± 20.7/87.1 ± 14.0 mm Hg for NEB subjects. Baseline ADMA was 0.32 ± 0.123 μmol/L in the MET group and 0.4035 ± 0.1378 in the NEB group. ADMA increased 44.78% and 72% in the MET group at weeks 4 and 8 (P < .05 for both), respectively, without increase in the NEB group. At week 8, augmentation index was increased in the MET group (P < .05). IGF-1 and endothelial progenitor cells were unchanged by treatment. Plasma ADMA and augmentation index are increased in a dose-dependent fashion by MET but not with NEB. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
7. Symptoms Characteristic of Heart Failure Among CKD Patients Without Diagnosed Heart Failure.
- Author
-
Shlipak, Michael G., Lash, James P., Yang, Wei, Teal, Valerie, Keane, Martin, Cappola, Tom, Keller, Chris, Jamerson, Kenneth, Kusek, John, Delafontaine, Patrice, He, Jiang, Miller, Edgar R., Schreiber, Martin, and Go, Alan S.
- Abstract
Abstract: Background: Epidemiological studies typically diagnose heart failure (HF) at the time of hospitalization, and have not evaluated the prevalence of HF symptoms in CKD patients without a prior HF diagnosis. Methods and Results: We modified the Kansas City Cardiomyopathy Questionnaire (KCCQ) to detect and quantify symptoms characteristic of HF (dyspnea, edema, and fatigue) among 2883 chronic kidney disease (CKD) patients without diagnosed heart failure in the Chronic Renal Insufficiency Cohort (CRIC). The KCCQ is a 23-item instrument that quantifies the impact of dyspnea, fatigue, and edema on physical, social, and emotional functions (scored 0 to 100). The median KCCQ score was 92, and 25% had KCCQ scores <75. Compared with cystatin C‑based estimated glomerular filtration rate >50 mL·min·1.73m
2 (reference), estimated glomerular filtration rate 40 to 50, 30 to 40, and <30 were independently associated with lower KCCQ scores (<75); adjusted odds ratios and (95% CI): 1.38 (1.06–1.78), 1.39 (1.09–1.82), and 2.15 (1.54–3.00), respectively. Lower hemoglobin (Hb) levels also had independent associations with KCCQ <75: Hb >14 g/dL (reference), Hb 13 to 14 g/dL (1.03; 0.76–1.40), Hb 12 to 13 g/dL (1.41; 1.04–1.91), Hb 11 to 12 g/dL (1.56; 1.12–2.16); and Hb <1 g/dL (1.65; 1.15–2.37). Conclusion: CKD patients without diagnosed HF have a substantial burden of symptoms characteristic of HF, particularly among those with lower estimated glomerular filtration rate and hemoglobin levels. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
8. Nonsteroidal Anti-Inflammatory drugs and cardiovascular risk
- Author
-
Howard, Patricia A. and Delafontaine, Patrice
- Subjects
- *
NONSTEROIDAL anti-inflammatory agents , *CYCLOOXYGENASES , *ENZYMES , *CARDIOVASCULAR diseases - Abstract
Nonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which exist in at least two isoforms, COX-1 and COX-2. Aspirin and older agents in this class are nonselective inhibitors of both COX-1 and COX-2. Newer agents termed “coxibs” are selective inhibitors of COX-2. Among the NSAID, only aspirin has been proven to significantly reduce cardiovascular risk, primarily through inhibition of COX-1-mediated platelet aggregation. It has been suggested that other nonselective agents, especially naproxen, may provide some lesser degree of cardioprotection, but conclusive evidence is lacking. Conversely, there are concerns that the COX-2 inhibitors may increase cardiovascular risk. However, mechanisms for this potentially adverse cardiovascular effect are unknown, and it is becoming increasingly clear that our understanding of the role of COX-2 in cardiovascular function is incomplete. Some studies have demonstrated a potentially beneficial effect of COX-2 on cardiovascular function that could be negated by COX-2 inhibition, while other studies have reported improved endothelial function with COX-2 inhibitors. Additionally, the impact of combined therapy with aspirin and other COX inhibitors is not yet clear. This article will review the studies that have examined these issues. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
9. Endovascular Stent-Graft Repair of Ascending Aortic Dissection With a Commercially Available Thoracic Endograft.
- Author
-
Atianzar, Kimberly, Mohamad, Almois, Galazka, Patrycja, Keller, V. Antoine, Delafontaine, Patrice, and Sam II, Albert D.
- Abstract
We describe the endovascular treatment of a type A thoracic aortic dissection (TAAD) in a patient deemed unfit for surgical repair with a commercially available thoracic endograft. A patient with a symptomatic acute TAAD, multiple medical comorbidities, and ascending thoracic aortic and arch dilation underwent successful endovascular repair with the use of a commercially available stent graft, resulting in complete resolution of his symptoms despite slight but persistent perigraft false lumen perfusion. Although surgical repair remains the gold standard, endografting has promise and may have a positive impact on the current treatment algorithm for TAAD. Advances must occur in graft manufacturing, and further data will be required before wider application is appropriate. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
10. Vitamin C and Percutaneous Coronary Intervention ⁎ [⁎] Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular ...
- Author
-
Delafontaine, Patrice and Anwar, Asif
- Published
- 2010
- Full Text
- View/download PDF
11. Angiotensin Type 2 Receptor Signaling in Satellite Cells Potentiates Skeletal Muscle Regeneration.
- Author
-
Tadashi Yoshida, Huq, Tashfin S., and Delafontaine, Patrice
- Subjects
- *
ANGIOTENSIN II , *CACHEXIA , *SKELETAL muscle , *SATELLITE cells , *MYOGENIN - Abstract
Patients with advanced congestive heart failure (CHF) or chronic kidney disease (CKD) often have increased angiotensin II (Ang II) levels and cachexia. Ang II infusion in rodents causes sustained skeletal muscle wasting and decreases muscle regenerative potential through Ang II type 1 receptor (AT1R)-mediated signaling, likely contributing to the development of cachexia in CHF and CKD. However, the potential role of Ang II type 2 receptor (AT2R) signaling in skeletal muscle physiology is unknown. We found that AT2R expression was increased robustly in regenerating skeletal muscle after cardiotoxin (CTX)-induced muscle injury in vivo and differentiating myoblasts in vitro, suggesting that the increase in AT2R played an important role in regulating myoblast differentiation and muscle regeneration. To determine the potential role of AT2R in muscle regeneration, we infused C57BL/6 mice with the AT2R antagonist PD123319 during CTX-induced muscle regeneration. PD123319 reduced the size of regenerating myofibers and expression of the myoblast differentiation markers myogenin and embryonic myosin heavy chain. On the other hand, AT2R agonist CGP42112 infusion potentiated CTX injury-induced myogenin and embryonic myosin heavy chain expression and increased the size of regenerating myofibers. In cultured myoblasts, AT2R knockdown by siRNA suppressed myoblast differentiation marker expression and myoblast differentiation via up-regulation of phos-pho-ERK1/2, and ERK inhibitor treatment completely blocked the effect of AT2R knockdown. These data indicate that AT2R signaling positively regulates myoblast differentiation and potentiates skeletal muscle regenerative potential, providing a new therapeutic target in wasting disorders such as CHF and CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. The therapeutic potential of IGF-I in skeletal muscle repair.
- Author
-
Song, Yao-Hua, Song, Jenny L., Delafontaine, Patrice, and Godard, Michael P.
- Subjects
- *
SOMATOMEDIN C , *SKELETAL muscle , *CELLULAR signal transduction , *MUSCLE diseases , *HUMAN genetic variation , *CLINICAL trials - Abstract
Highlights: [•] IGF-I signaling is important in skeletal muscle maintenance and repair. [•] IGF-I can reverse various muscle wasting conditions in experimental models. [•] The potential therapeutic effect of novel IGF-I formulations and biodegradable IGF-I variants must be explored in clinical trials. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
13. Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor y-Independent Pathway.
- Author
-
Higashi, Yusuke, Holder, Kevin, and Delafontaine, Patrice
- Subjects
- *
SOMATOMEDIN , *PEROXISOMES , *HYPOGLYCEMIC agents , *ROSIGLITAZONE , *APOPTOSIS , *GENETIC regulation - Abstract
There is increasing evidence that thiazolidinediones (TZDs), antidiabetic compounds that are synthetic ligands for the peroxisome proliferator-activated receptor γ (PPARγ), have cardiovascular effects through as yet poorly defined mechanisms. We tested the effect of two TZD class drugs, rosiglitazone and pioglitazone, on human aortic smooth muscle cell (SMC) expression of insulin-like growth factor-1 receptor (IGF-1R). Both TZDs dose dependently up-regulated IGF-1R protein levels (rosiglitazone, 10 μmol/liter, 67% increase, n = 4, p < 0.01; pioglitazone, 10 μmol/liter, 41% increase, n = 4, p < 0.01) and increased IGF-1R signaling activity (36% increase in Akt phosphorylation). However, the endogenous PPARγ ligand, 15-deoxy-Δ12,14-prostaglandin J2, dose dependently reduced IGF-1R (10 μmol/liter, 80% decrease, n = 4, p < 0.01), and overexpression of PPARγ using an adenovirus likewise reduced IGF-1R (50% decrease versus SMC infected with control adenovirus), suggesting a PPARγ-independent action of TZDs. All three PPARγ ligands (rosiglitazone, pioglitazone, and 15-deoxy-Δ12,14-prostaglandin J2), however, did not change IGF-1R mRNA levels, indicating that their effects were posttranscriptional. Use of bicistronic constructs revealed that TZD induction of IGF-1R translation occurred via internal ribosomal entry. To examine the potential physiological relevance of TZD up-regulation of IGF-1R, we determined the effect of rosiglitazone on oxidized LDL (oxLDL)-induced apoptosis. 20 μmol/liter of rosiglitazone reduced oxidized LDL-induced apoptosis by 40% and neutralizing antibody to IGF-1R (αIR3) counteracted this rescue, suggesting the rosiglitazone survival effect was, at least in part, mediated by IGF-1R. In conclusion, TZDs markedly up-regulate SMC IGF-1R expression and signaling, likely via a PPARγ-independent mechanism. This novel action of TZDs may play an important role in their cardiovascular effects. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
14. Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.
- Author
-
Higashi, Yusuke, Mummidi, Srinivas, Sukhanov, Sergiy, Yoshida, Tadashi, Noda, Makoto, Delafontaine, Patrice, and Chandrasekar, Bysani
- Subjects
- *
MINOCYCLINE , *ANTIBACTERIAL agents , *HOMODIMERS , *SMOOTH muscle , *CELL proliferation , *VASCULAR diseases - Abstract
Abstract Minocycline, a tetracycline antibiotic, is known to exert vasculoprotective effects independent of its anti-bacterial properties; however the underlying molecular mechanisms are not completely understood. Reversion Inducing Cysteine Rich Protein with Kazal Motifs (RECK) is a cell surface expressed, membrane anchored protein, and its overexpression inhibits cancer cell migration. We hypothesized that minocycline inhibits platelet-derived growth factor (PDGF)-induced human aortic smooth muscle cell (SMC) proliferation and migration via RECK upregulation. Our data show that the BB homodimer of recombinant PDGF (PDGF-BB) induced SMC migration and proliferation, effects significantly blunted by pre-treatment with minocycline. Further investigations revealed that PDGF-BB induced PI3K-dependent AKT activation, ERK activation, reactive oxygen species generation, Nuclear Factor-κB and Activator Protein-1 activation, microRNA (miR)-221 and miR-222 induction, RECK suppression, and matrix metalloproteinase (MMP2 and 9) activation, effects that were reversed by minocycline. Notably, minocycline induced RECK expression dose-dependently within the therapeutic dose of 1–100 μM, and silencing RECK partially reversed the inhibitory effects of minocycline on PDGF-BB-induced MMP activation, and SMC proliferation and migration. Further, targeting MMP2 and MMP9 blunted PDGF-BB-induced SMC migration. Together, these results demonstrate that minocycline inhibits PDGF-BB-induced SMC proliferation and migration by restoring RECK, an MMP inhibitor. These results indicate that the induction of RECK is one of the mechanisms by which minocycline exerts vasculoprotective effects. Highlights • PDGF suppresses RECK, and induces SMC migration and proliferation • Minocycline induces RECK expression • Minocycline reverses PDGF-induced SMC migration and proliferation • RECK inducers have the potential to block vascular proliferative diseases [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.
- Author
-
Sakamuri, Siva S.V.P., Valente, Anthony J., Siddesha, Jalahalli M., Delafontaine, Patrice, Siebenlist, Ulrich, Gardner, Jason D., and Bysani, Chandrasekar
- Subjects
- *
HEART fibrosis , *THERAPEUTICS , *HEART diseases , *CARDIAC hypertrophy , *VENTRICULAR remodeling , *RENIN-angiotensin system , *TRANSCRIPTION factor AP-1 , *GENE expression - Abstract
Aberrant activation of the renin-angiotensin-aldosterone system (RAAS) contributes to adverse cardiac remodeling and eventual failure. Here we investigated whether TRAF3 Interacting Protein 2 (TRAF3IP2), a redox-sensitive cytoplasmic adaptor molecule and an upstream regulator of nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), mediates aldosterone-induced cardiac hypertrophy and fibrosis. Wild type (WT) and TRAF3IP2-null mice were infused with aldosterone (0.2 mg/kg/day) for 4 weeks along with 1%NaCl in drinking water. Aldosterone/salt, but not salt alone, upregulated TRAF3IP2 expression in WT mouse hearts. Further, aldosterone elevated blood pressure to a similar extent in both WT and TRAF3IP2-null groups. However, TRAF3IP2 gene deletion attenuated aldosterone/salt-induced (i) p65 and c-Jun activation, (ii) extracellular matrix (collagen Iα1 and collagen IIIα1), matrix metalloproteinase (MMP2), lysyl oxidase (LOX), inflammatory cytokine (IL-6 and IL-18), chemokine (CXCL1 and CXCL2), and adhesion molecule (ICAM1) mRNA expression in hearts, (iii) IL-6, IL-18, and MMP2 protein levels, (iv) systemic IL-6 and IL-18 levels, and (iv) cardiac hypertrophy and fibrosis. These results indicate that TRAF3IP2 is a critical signaling intermediate in aldosterone/salt-induced myocardial hypertrophy and fibrosis, and thus a potential therapeutic target in hypertensive heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.
- Author
-
Siddesha, Jalahalli M., Valente, Anthony J., Yoshida, Tadashi, Sakamuri, Siva S.V.P., Delafontaine, Patrice, Iba, Hideo, Noda, Makoto, and Chandrasekar, Bysani
- Subjects
- *
DOCOSAHEXAENOIC acid , *ANGIOTENSIN II , *CYSTEINE proteinases , *CELL migration , *OMEGA-3 fatty acids , *HEART fibrosis , *GENE expression - Abstract
Abstract: The omega-3 polyunsaturated fatty acids (ω−3 fatty acids) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been reported to inhibit or delay the progression of cardiovascular diseases, including myocardial fibrosis. Recently we reported that angiotensin II (Ang II) promotes cardiac fibroblast (CF) migration by suppressing the MMP regulator reversion-inducing-cysteine-rich protein with Kazal motifs (RECK), through a mechanism dependent on AT1, ERK, and Sp1. Here we investigated the role of miR-21 in Ang II-mediated RECK suppression, and determined whether the ω−3 fatty acids reverse these effects. Ang II induced miR-21 expression in primary mouse cardiac fibroblasts (CFs) via ERK-dependent AP-1 and STAT3 activation, and while a miR-21 inhibitor reversed Ang II-induced RECK suppression, a miR-21 mimic inhibited both RECK expression and Ang II-induced CF migration. Moreover, Ang II suppressed the pro-apoptotic PTEN, and the ERK negative regulator Sprouty homologue 1 (SPRY1), but induced the metalloendopeptidase MMP2, all in a manner that was miR-21-dependent. Further, forced expression of PTEN inhibited Akt phosphorylation, Sp1 activation, and MMP2 induction. Notably, while both EPA and DHA reversed Ang II-mediated RECK suppression, DHA appeared to be more effective, and reversed Ang II-induced miR-21 expression, RECK suppression, MMP2 induction, and CF migration. These results indicate that Ang II-induced CF migration is differentially regulated by miR-21-mediated MMP induction and RECK suppression, and that DHA has the potential to upregulate RECK, and therefore may exert potential beneficial effects in cardiac fibrosis. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
17. Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5' Stem-loop of COL1a1 and COL1a2 mRNA.
- Author
-
Blackstock, Christopher D., Yusuke Higashi, Sukhanov, Sergiy, Shaw-Yung Shai, Stefanovic, Branko, Tabony, A. Michael, Tadashi Yoshida, and Delafontaine, Patrice
- Subjects
- *
INSULIN-like growth factor-binding proteins , *SOMATOMEDIN C , *MESSENGER RNA , *EXTRACELLULAR matrix proteins , *IMMUNOPRECIPITATION , *ATHEROSCLEROTIC plaque - Abstract
Collagen content in atherosclerotic plaque is a hallmark of plaque stability. Our earlier studies showed that insulin-like growth factor-1 (IGF-1) increases collagen content in atherosclerotic plaques of Apoe-/- mice. To identify mechanisms we investigated the effect of IGF-1 on the la ribonucleoprotein domain family member 6 (LARP6). LARP6 binds a stem-loop motif in the 5'-UTR of them RNAs encoding the collagen type I α-subunits (α1(I) and α2(I)), and coordinates their translation into the heterotrimeric collagen type I molecule. In human aortic smooth muscle cells (SMCs), IGF-1 rapidly increased LARP6 expression and the rate of collagen synthesis and extracellular accumulation. IGF-1 increased both LARP6 and collagen type I expression via a post-transcriptional and translation-dependent mechanism involving PI3K/Akt/p70S6k-signaling. Immunoprecipitation of LARP6, followed by qPCR indicated that IGF-1 increased the level of COL1a1 and COL1a2 mRNA bound to LARP6. Mutation of the 5' stem-loop of Col1a1 mRNA, which inhibits binding of LARP6, abolished the ability of IGF-1 to increase synthesis of collagen type I. Furthermore, overexpression of a 5' stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IGF-1 to increase pro-α1(I) and mature α1(I) expression in cultured medium. IGF-1 infusion in Apoe -/- mice increased expression of LARP6 and pro-α1(I) in aortic lysates, and SMC-specific IGF-1-overexpression robustly increased collagen fibrillogenesis in atherosclerotic plaque. In conclusion, we identify LARP6 as a critical mediator by which IGF-1 augments synthesis of collagen type I in vascular smooth muscle, which may play an important role in promoting atherosclerotic plaque stability. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia.
- Author
-
Yoshida, Tadashi, Tabony, A. Michael, Galvez, Sarah, Mitch, William E., Higashi, Yusuke, Sukhanov, Sergiy, and Delafontaine, Patrice
- Subjects
- *
ANGIOTENSIN II , *WASTING syndrome , *CACHEXIA treatment , *HEART failure , *MUSCULAR atrophy , *RENIN-angiotensin system - Abstract
Abstract: Cachexia is a serious complication of many chronic diseases, such as congestive heart failure (CHF) and chronic kidney disease (CKD). Many factors are involved in the development of cachexia, and there is increasing evidence that angiotensin II (Ang II), the main effector molecule of the renin–angiotensin system (RAS), plays an important role in this process. Patients with advanced CHF or CKD often have increased Ang II levels and cachexia, and angiotensin-converting enzyme (ACE) inhibitor treatment improves weight loss. In rodent models, an increase in systemic Ang II leads to weight loss through increased protein breakdown, reduced protein synthesis in skeletal muscle and decreased appetite. Ang II activates the ubiquitin–proteasome system via generation of reactive oxygen species and via inhibition of the insulin-like growth factor-1 signaling pathway. Furthermore, Ang II inhibits 5′ AMP-activated protein kinase (AMPK) activity and disrupts normal energy balance. Ang II also increases cytokines and circulating hormones such as tumor necrosis factor-α, interleukin-6, serum amyloid-A, glucocorticoids and myostatin, which regulate muscle protein synthesis and degradation. Ang II acts on hypothalamic neurons to regulate orexigenic/anorexigenic neuropeptides, such as neuropeptide-Y, orexin and corticotropin-releasing hormone, leading to reduced appetite. Also, Ang II may regulate skeletal muscle regenerative processes. Several clinical studies have indicated that blockade of Ang II signaling via ACE inhibitors or Ang II type 1 receptor blockers prevents weight loss and improves muscle strength. Thus the RAS is a promising target for the treatment of muscle atrophy in patients with CHF and CKD. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
19. Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration.
- Author
-
Yoshida, Tadashi, Galvez, Sarah, Tiwari, Sumit, Rezk, Bashir M., Semprun-Prieto, Laura, Higashi, Yusuke, Sukhanov, Sergiy, Yablonka-Reuveni, Zipora, and Delafontaine, Patrice
- Subjects
- *
ANGIOTENSIN II , *CONGESTIVE heart failure , *KIDNEY diseases , *SKELETAL muscle , *CELL proliferation , *MUSCLE regeneration , *STEM cell research - Abstract
Cachexia is a serious complication of many chronic diseases, such as congestive heart failure (CHF) and chronic kidney disease (CKD). Although patients with advanced CHF or CKD often have increased angiotensin II (Ang II) levels and cachexia and Ang II causes skeletalmuscle wasting in rodents, the potential effects of Ang II onmuscle regeneration are unknown.Muscle regeneration is highly dependent on the ability of a pool of muscle stem cells (satellite cells) to proliferate and to repair damaged myofibers or form new myofibers. Here we show that Ang II reduced skeletal muscle regeneration via inhibition of satellite cell (SC) proliferation. Ang II reduced the number of regenerating myofibers and decreased expression of SC proliferation/differentiation markers (MyoD, myogenin, and active-Notch) after cardiotoxin-induced muscle injury in vivo and in SCs cultured in vitro. Ang II depleted the basal pool of SCs, as detected in Myf5nLacZ/+ mice and by FACS sorting, and this effect was inhibited by Ang II AT1 receptor (AT1R) blockade and inAT1aR-nullmice.AT1Rwas highly expressed in SCs, and Notch activation abrogated the AT1R-mediated antiprolifera- tive effect ofAng II in cultured SCs. Inmice that developed CHF postmyocardial infarction, there was skeletal muscle wasting and reduced SCnumbers that were inhibited byAT1R blockade. Ang II inhibition of skeletal muscle regeneration via AT1 receptor-dependent suppression of SC Notch and MyoD signaling and proliferation is likely to play an important role in mechanisms leading to cachexia in chronic disease states such as CHF and CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
20. Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.
- Author
-
Valente, Anthony J., Yoshida, Tadashi, Clark, Robert A., Delafontaine, Patrice, Siebenlist, Ulrich, and Chandrasekar, Bysani
- Subjects
- *
HEART cells , *CELL death , *RAS proteins , *SUPEROXIDES , *JNK mitogen-activated protein kinases , *CELLULAR signal transduction , *LABORATORY mice - Abstract
Abstract: Advanced oxidation protein products (AOPPs) are formed during chronic oxidative stress as a result of reactions between plasma proteins and chlorinated oxidants. Their levels are elevated during various cardiovascular diseases. Because elevated AOPPs serve as independent risk factors for ischemic heart disease, and cardiomyocyte death is a hallmark of ischemic heart disease, we hypothesized that AOPPs will induce cardiomyocyte death. AOPP-modified mouse serum albumin (AOPP-MSA) induced significant death of neonatal mouse cardiomyocytes that was attenuated by knockdown of the receptor for advanced glycation end products, but not CD36. Notably, TRAF3-interacting protein 2 (TRAF3IP2; also known as CIKS or Act1) knockdown blunted AOPP-induced apoptosis. AOPP-MSA stimulated Nox2/Rac1-dependent superoxide generation, TRAF3IP2 expression, and TRAF3IP2-dependent JNK activation. The superoxide anion generating xanthine/xanthine oxidase system and hydrogen peroxide both induced TRAF3IP2 expression. Further, AOPP-MSA induced mitochondrial Bax translocation and release of cytochrome c into cytoplasm. Moreover, AOPP-MSA suppressed antiapoptotic Bcl-2 and Bcl-xL expression. These effects were reversed by TRAF3IP2 knockdown or forced expression of mutant JNK. Similar to its effects in neonatal cardiomyocytes, AOPP-MSA induced adult cardiomyocyte death in part via TRAF3IP2. These results demonstrate for the first time that AOPPs induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK activation in vitro and suggest that AOPPs may contribute to myocardial injury in vivo. Thus TRAF3IP2 may represent a potential therapeutic target in ischemic heart disease. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
21. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.
- Author
-
Valente, Anthony J., Yoshida, Tadashi, Izadpanah, Reza, Delafontaine, Patrice, Siebenlist, Ulrich, and Chandrasekar, Bysani
- Subjects
- *
INTERLEUKIN-18 , *PROTEIN binding , *SMOOTH muscle , *MUSCLE cells , *CELL migration , *SIMVASTATIN - Abstract
Abstract: We investigated the role of TRAF3 interacting protein 2 (TRAF3IP2), a redox-sensitive adapter protein and an upstream regulator of IKK and JNK in interleukin (IL)-18 induced smooth muscle cell migration, and the mechanism of its inhibition by simvastatin. The pleiotropic cytokine IL-18 induced human coronary artery SMC migration through the induction of TRAF3IP2. IL-18 induced Nox1-dependent ROS generation, TRAF3IP2 expression, and IKK/NF-κB and JNK/AP-1 activation. IL-18 induced its own expression and that of its receptor subunit IL-18Rα. Using co-IP/IB and GST pull-down assays, we show for the first time that the subunits of the IL-18R heterodimer physically associate with Nox1 under basal conditions, and IL-18 appears to enhance their binding. Importantly, the HMG-coA reductase inhibitor simvastatin attenuated IL-18-induced TRAF3IP2 induction. These inhibitory effects were reversed by mevalonate and geranylgeranylpyrophosphate (GGPP), but not by farnesylpyrophosphate (FPP). Interestingly, simvastatin, GGPP, FPP, or Rac1 inhibition did not modulate ectopically expressed TRAF3IP2. These results demonstrate that the promigratory effects of IL-18 are mediated through TRAF3IP2 in a redox-sensitive manner, and this may involve IL-18R/Nox1 physical association. Further, Simvastatin inhibits inducible, but not ectopically-xpressed TRAF3IP2. Targeting TRAF3IP2 may blunt progression of hyperplastic vascular diseases in vivo. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
22. Effect of Hurricane Katrina on Chronobiology at Onset of Acute Myocardial Infarction During the Subsequent Three Years.
- Author
-
Peters, Matthew N., Katz, Morgan J., Moscona, John C., Alkadri, Mohi E., Khazi Syed, Rashad H., Turnage, Thomas A., Nijjar, Vikram S., Bisharat, Mohannad B., Delafontaine, Patrice, and Irimpen, Anand M.
- Subjects
- *
HURRICANE Katrina, 2005 , *CHRONOBIOLOGY disorders , *MYOCARDIAL infarction , *NATURAL disasters , *CATASTROPHIC illness , *BIOLOGICAL rhythms - Abstract
The onset of acute myocardial infarction (AMI) has been shown to occur in a nonrandom pattern, with peaks in midmorning and on weekdays (especially Monday). The incidence of AMI has been shown to increase locally after natural disasters, but the effect of catastrophic events on AMI biorhythms is largely unknown. To assess the differences in the chronobiology of AMI in residents of New Orleans before and after Hurricane Katrina, the onset of AMI in patients at Tulane University Health Sciences Center in the 6 years before and the 3 years after Hurricane Katrina was retrospectively examined. Compared to the pre-Katrina group, the post-Katrina cohort demonstrated significant decreases in the onset of AMI during mornings (p [ 0.002), Mondays (p <0.0001), and weekdays (p <0.0001) and significant increases in onset during weekends (p <0.0001) and nights (p <0.0001). These changes persisted during all 3 years after the storm. In conclusion, the normal pattern of AMI onset was altered after Hurricane Katrina, and expected morning, weekday, and Monday peaks were eliminated. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
23. Insulin-like growth factor-1 regulates glutathione peroxidase expression and activity in vascular endothelial cells: Implications for atheroprotective actions of insulin-like growth factor-1
- Author
-
Higashi, Yusuke, Pandey, Arvind, Goodwin, Brett, and Delafontaine, Patrice
- Subjects
- *
SOMATOMEDIN C , *GLUTATHIONE peroxidase , *VASCULAR endothelial cells , *OXIDATIVE stress , *APOLIPOPROTEIN E , *REACTIVE oxygen species - Abstract
Abstract: Oxidative stress promotes endothelial cell senescence and endothelial dysfunction, important early steps in atherogenesis. To investigate potential antioxidant effects of IGF-1 we treated human aortic endothelial cells (hAECs) with 0–100ng/mL IGF-1 prior to exposure to native or oxidized low-density lipoprotein (oxLDL). IGF-1 dose- and time- dependently reduced basal- and oxLDL-induced ROS generation. IGF-1 did not alter superoxide dismutase or catalase activity but markedly increased activity of glutathione peroxidase (GPX), a crucial antioxidant enzyme, via a phosphoinositide-3 kinase dependent pathway. IGF-1 did not increase GPX1 mRNA levels but increased GPX1 protein levels by 2.6-fold at 24h, and altered selenocysteine-incorporation complex formation on GPX1 mRNA. Furthermore, IGF-1 blocked hydrogen peroxide induced premature cell senescence in hAECs. In conclusion, IGF-1 upregulates GPX1 expression in hAECs via a translational mechanism, which may play an important role in the ability of IGF-1 to reduce endothelial cell oxidative stress and premature senescence. Our findings have major implications for understanding vasculoprotective effects of IGF-1. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
24. Effect of Hurricane Katrina on Incidence of Acute Myocardial Infarction in New Orleans Three Years After the Storm
- Author
-
Jiao, Zhen, Kakoulides, Socrates V., Moscona, John, Whittier, Jabar, Srivastav, Sudesh, Delafontaine, Patrice, and Irimpen, Anand
- Subjects
- *
MYOCARDIAL infarction , *HURRICANE Katrina, 2005 , *HEALTH insurance , *DIABETES - Abstract
To detect a long-term increase in the incidence of acute myocardial infarction (AMI) after Hurricane Katrina and to investigate the pertinent contributing factors, we conducted a single-center retrospective cohort observational study. The patients admitted with AMI to Tulane University Hospital in the 2 years before Katrina and the 3 years after the hospital reopened were identified from the hospital medical records. The pre- and post-Katrina groups were compared for prespecified demographic and clinical data. In the 3-year post-Katrina group, 418 admissions (2.0%) for AMI occurred of a total census of 21,092 patients compared to 150 (0.7%) of a census of 21,079 in the 2-year pre-Katrina group (p <0.0001). The post-Katrina group had a greater prevalence of unemployment (p <0.0001), lack of medical insurance (p <0.001), smokers (p <0.01), medical noncompliance (p <0.0001), first-time hospitalizations (p <0.001), history of coronary artery disease (p <0.01), multiple vessel disease (p <0.05), and percutaneous coronary interventions (p <0.0001). The mean age of onset of AMI decreased from 62 years before Katrina to 59 years after Katrina (p <0.05), and a significantly greater percentage of patients were men (p <0.05). No significant differences were found between the two groups in terms of race, substance abuse, and a history of hypertension or diabetes mellitus. Our data suggest that chronic stress after natural disasters may significantly affect cardiovascular risk factors such as tobacco abuse and increase medical noncompliance. In conclusion, our data is consistent with a significant change in the overall health of the population and support the need for additional study into the health effects of chronic stress after natural disasters. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
25. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1
- Author
-
Valente, Anthony J., Yoshida, Tadashi, Gardner, Jason D., Somanna, Naveen, Delafontaine, Patrice, and Chandrasekar, Bysani
- Subjects
- *
INTERLEUKIN-17 , *FIBROBLASTS , *PHOSPHATASES , *MITOGEN-activated protein kinases , *DEPHOSPHORYLATION , *LABORATORY mice , *IMMUNOSUPPRESSION , *CELL proliferation , *CELL migration - Abstract
Abstract: The dual-specificity mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) inactivates MAP kinases by dephosphorylation. Here we show that the proinflammatory cytokine interleukin (IL)-17A induces adult mouse primary cardiac fibroblast (CF) proliferation and migration via IL-17 receptor A//IL-17 receptor C-dependent MKP-1 suppression, and activation of p38 MAPK and ERK1/2. IL-17A mediated p38 MAPK and ERK1/2 activation is inhibited by MKP-1 overexpression, but prolonged by MKP-1 knockdown. IL-17A induced miR-101 expression via PI3K/Akt, and miR-101 inhibitor reversed MKP-1 down regulation. Importantly, MKP-1 knockdown, pharmacological inhibition of p38 MAPK and ERK1/2, or overexpression of dominant negative MEK1, each markedly attenuated IL-17A-mediated CF proliferation and migration. Similarly, IL-17F and IL-17A/F heterodimer that also signal via IL-17RA/IL-17RC, stimulated CF proliferation and migration. These results indicate that IL-17A stimulates CF proliferation and migration via Akt/miR-101/MKP-1-dependent p38 MAPK and ERK1/2 activation. These studies support a potential role for IL-17 in cardiac fibrosis and adverse myocardial remodeling. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
26. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death
- Author
-
Venkatesan, Balachandar, Prabhu, Sumanth D., Venkatachalam, Kaliyamurthi, Mummidi, Srinivas, Valente, Anthony J., Clark, Robert A., Delafontaine, Patrice, and Chandrasekar, Bysani
- Subjects
- *
WNT proteins , *CELLULAR signal transduction , *CELL growth , *DOXORUBICIN , *HEART cells , *CELL death , *MITOGEN-activated protein kinases , *CARRIER proteins - Abstract
Abstract: The anthracycline antibiotic doxorubicin (DOX) is a potent cancer chemotherapeutic agent that exerts both acute and chronic cardiotoxicity. Here we show that in adult mouse cardiomyocytes, DOX activates (i) the pro-apoptotic p53, (ii) p38MAPK and JNK, (iii) Bax translocation, (iv) cytochrome c release, and (v) caspase 3. Further, it (vi) inhibits expression of anti-apoptotic Akt, Bcl-2 and Bcl-xL, and (vii) induces internucleosomal degradation and cell death. WNT1-inducible signaling pathway protein-1 (WISP1), a CCN family member and a matricellular protein, inhibits DOX-mediated cardiomyocyte death. WISP1 inhibits DOX-induced p53 activation, p38 MAPK and JNK phosphorylation, Bax translocation to mitochondria, and cytochrome c release into cytoplasm. Additionally, WISP1 reverses DOX-induced suppression of Bcl-2 and Bcl-xL expression and Akt inhibition. The pro-survival effects of WISP1 were recapitulated by the forced expression of mutant p53, wild-type Bcl-2, wild-type Bcl-xL, or constitutively active Akt prior to DOX treatment. WISP1 also induces the pro-survival factor Survivin via PI3K/Akt signaling. Overexpression of wild-type, but not mutant Survivin, blunts DOX cytotoxicity. Further, WISP1 stimulates PI3K–Akt-dependent GSK3β phosphorylation and β-catenin nuclear translocation. Importantly, WISP1 induces its own expression. Together, these results provide important insights into the cytoprotective effects of WISP1 in cardiomyocytes, and suggest a potential therapeutic role for WISP1 in DOX-induced cardiotoxicity. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
27. IGF-1, oxidative stress and atheroprotection
- Author
-
Higashi, Yusuke, Sukhanov, Sergiy, Anwar, Asif, Shai, Shaw-Yung, and Delafontaine, Patrice
- Subjects
- *
SOMATOMEDIN , *OXIDATIVE stress , *ATHEROSCLEROSIS , *LIPOPROTEINS , *THROMBOSIS , *CELL proliferation , *CELL migration , *VASCULAR endothelial growth factors - Abstract
Atherosclerosis is a chronic inflammatory disease in which early endothelial dysfunction and subintimal modified lipoprotein deposition progress to complex, advanced lesions that are predisposed to erosion, rupture and thrombosis. Oxidative stress plays a crucial role not only in initial lesion formation but also in lesion progression and destabilization. Although most growth factors are thought to promote vascular smooth muscle cell proliferation and migration, thereby increasing neointima, recent animal studies indicate that insulin-like growth factor (IGF)-1 exerts both pleiotropic anti-oxidant effects and anti-inflammatory effects, which together reduce atherosclerotic burden. This review discusses the effects of IGF-1 in models of vascular injury and atherosclerosis, emphasizing the relationship between oxidative stress and potential atheroprotective actions of IGF-1. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
28. Predictors of Left Ventricular Dilatation in Young Adults (from the Bogalusa Heart Study)
- Author
-
Haji, Showkat A., Ulusoy, Rifat Eralp, Patel, Dharmendrakumar A., Srinivasan, Sathanur R., Chen, Wei, Delafontaine, Patrice, and Berenson, Gerald S.
- Subjects
- *
HEART diseases , *BLOOD pressure , *DIAGNOSTIC ultrasonic imaging , *HYPERTENSION - Abstract
Left ventricular (LV) dilatation may be an early sign of cardiac decompensation progressing to LV dysfunction. Determinants of LV dilatation in young asymptomatic adults are unknown. Five hundred six asymptomatic subjects (mean age 32 ± 3 years) enrolled in the Bogalusa Heart Study underwent echocardiographic examination. LV dilatation (LV end-diastolic diameter >5.5 cm) as measured by M-mode echocardiography was found in 31 subjects (6%). Subjects with LV dilatation had greater body mass indexes (32 ± 9 vs 27 ± 6 kg/m2, p <0.0001), systolic (119 ± 15 vs 112 ± 12 mm Hg, p = 0.007) and diastolic (79 ± 12 vs 75 ± 9 mm Hg, p = 0.04) blood pressures, and LV mass (230 ± 50 vs 123 ± 39 g, p <0.0001). Age, gender, race, and metabolic parameters (glucose, insulin, and lipoprotein levels) did not differ significantly between the subjects with and without LV dilatation. After correction for age, gender, and race differences, adulthood obesity (body mass index >30 kg/m2) was associated with a threefold odds ratio (2.9, 95% confidence interval 1.4 to 6.1), and hypertension (defined as per the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) was also associated with a threefold odds ratio (3.0, 95% confidence interval 1.2 to 7.1) for an increased incidence of LV dilatation. There was an incremental increase in LV end-diastolic dimension depending on the presence of hypertension or obesity, and subjects with obesity and hypertension in adulthood had the greatest degree of LV end-diastolic dimensions. In multiple regression analyses, body mass index in childhood was the only significant predictor of LV dilatation in adulthood (odds ratio 1.47, 95% confidence interval 1.03 to 2.09). In conclusion, obesity beginning in childhood and obesity and hypertension in young adulthood are predictors of LV dilatation in an otherwise healthy young adult population. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
29. HURRICANE KATRINA AND MYOCARDIAL INFARCTION INCIDENCE: SEVEN YEARS AFTER THE STORM.
- Author
-
Peters, Matthew N., Deandrade, Kevin, Diaz, Henry Quevedo, Andrew, Burchett R., Tiwari, Sumit, Singh, Kanwar, Turnage, Thomas A., Fomunung, Edmond N., Gonzales, Holly, Srivastav, Sudesh, Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2014
- Full Text
- View/download PDF
30. HURRICANE KATRINA AND THE TIMING OF MYOCARDIAL INFARCTION: SEVEN YEARS AFTER THE STORM.
- Author
-
Peters, Matthew N., Deandrade, Kevin, Diaz, Henry Quevedo, Burchett, Andrew R., Tiwari, Sumit, Singh, Kanwar, Turnage, Thomas A., Fomunung, Edmond N., Gonzales, Holly, Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2014
- Full Text
- View/download PDF
31. THE EFFECTS OF A GROWTH HORMONE-RELEASING HORMONE ANTAGONIST AND A GASTRIN-RELEASING PEPTIDE ANTAGONIST ON INTIMAL HYPERPLASIA OF THE CAROTID ARTERY AFTER BALLOON INJURY IN A DIABETIC RAT MODEL
- Author
-
Moscona, John, Khan, Zia, Schally, Andrew V., Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2013
- Full Text
- View/download PDF
32. ALTERATION IN THE CHRONOBIOLOGY OF ONSET OF ACUTE MYOCARDIAL INFARCTION IN NEW ORLEANS RESIDENTS FOLLOWING HURRICANE KATRINA
- Author
-
Peters, Matthew N., Katz, Morgan J., Moscona, John C., Alkadri, Mohi E., Syed, Rashad K., Turnage, Thomas A., Nijjar, Vikram S., Bisharat, Mohannad B., Delafontaine, Patrice, and Irimpen, Anand M.
- Published
- 2013
- Full Text
- View/download PDF
33. INCREASED INCIDENCE OF ACUTE CORONARY SYNDROME FOLLOWING HURRICANE KATRINA IN NEW ORLEANS: THE IMPACT CONTINUES
- Author
-
Moscona, John, Tiwari, Sumit, DeAndrade, Kevin, Quevedo, Henry, Peters, Matthew, Munshi, Kartik, Sudesh, Srivastav, Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2013
- Full Text
- View/download PDF
34. THE EFFECTS OF HURRICANE KATRINA ON ACUTE MYOCARDIAL INFARCTION FIVE YEARS AFTER THE STORM
- Author
-
Moscona, John, Tiwari, Sumit, Munshi, Kartik, Srivastav, Sudesh, Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2012
- Full Text
- View/download PDF
35. ASYMMETRIC DIMETHYLARGININE IS INCREASED BY METOPROLOL SUCCINATE, BUT NOT BY NEBIVOLOL, IN HYPERTENSION
- Author
-
Giles, Thomas D., Kandavar, Ramprasad, Higashi, Yusuke, Chen, Wei, Blackstock, Christopher, Sukhanov, Sergiy, Sander, Gary, Roffidal, Louise, and Delafontaine, Patrice
- Published
- 2011
- Full Text
- View/download PDF
36. ACUTE MYOCARDIAL INFARCTION BEFORE AND AFTER THE STORM: HURRICANE KATRINA
- Author
-
Hameed, Irfan, Kakoulides, Socrates, Moscona, John, Srivastav, Sudesh, Jiao, Zhen, Delafontaine, Patrice, and Irimpen, Anand
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.